1
|
Jakopec S, Hamzic LF, Bočkor L, Car I, Perić B, Kirin SI, Sedić M, Raić-Malić S. Coumarin-modified ruthenium complexes: Synthesis, characterization, and antiproliferative activity against human cancer cells. Arch Pharm (Weinheim) 2024:e2400271. [PMID: 38864840 DOI: 10.1002/ardp.202400271] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 04/11/2024] [Revised: 05/22/2024] [Accepted: 05/26/2024] [Indexed: 06/13/2024]
Abstract
Among ruthenium complexes studied as anticancer metallodrugs, NKP-1339, NAMI-A, RM175, and RAPTA-C have already entered clinical trials due to their potent antitumor activity demonstrated in preclinical studies and reduced toxicity in comparison with platinum drugs. Considering the advantages of ruthenium-based anticancer drugs and the cytostatic activity of organometallic complexes with triazole- and coumarin-derived ligands, we set out to synthesize Ru(II) complexes of coumarin-1,2,3,-triazole hybrids (L) with the general formula [Ru(L)(p-cymene)(Cl)]ClO4. The molecular structure of the complex [Ru(2a)(p-cymene)(Cl)]ClO4 (2aRu) was determined by single-crystal X-ray diffraction, which confirmed the coordination of the ligand to the central ruthenium(II) cation by bidentate mode of coordination. Coordination with Ru(II) resulted in the enhancement of cytostatic activity in HepG2 hepatocellular carcinoma cells and PANC-1 pancreatic cancer cells. Coumarin derivative 2a positively regulated the expression and activity of c-Myc and NPM1 in RKO colon carcinoma cells, while the Ru(II) half-sandwich complex 2cRu induced downregulation of AKT and ERK signaling in PANC-1 cells concomitant with reduced intracellular levels of reactive oxygen species. Altogether, our findings indicated that coumarin-modified half-sandwich Ru(II) complexes held potential as anticancer agents against gastrointestinal malignancies.
Collapse
Affiliation(s)
- Silvio Jakopec
- Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia
| | - Lejla F Hamzic
- Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia
| | - Luka Bočkor
- Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia
| | - Iris Car
- Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia
| | - Berislav Perić
- Division of Materials Chemistry, Ruđer Bošković Institute, Zagreb, Croatia
| | - Srećko I Kirin
- Division of Materials Chemistry, Ruđer Bošković Institute, Zagreb, Croatia
| | - Mirela Sedić
- Centre for Applied Bioanthropology, Institute for Anthropological Research, Zagreb, Croatia
| | - Silvana Raić-Malić
- Department of Organic Chemistry, Faculty of Chemical Engineering and Technology, University of Zagreb, Zagreb, Croatia
| |
Collapse
|
2
|
Bhat AR, Patel R. Exploring the binding mechanism and esterase-like activity of human serum albumin with levofloxacin and its choline based conjugates: A biophysical approach. Int J Biol Macromol 2024; 274:133011. [PMID: 38852730 DOI: 10.1016/j.ijbiomac.2024.133011] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 03/26/2024] [Revised: 06/05/2024] [Accepted: 06/06/2024] [Indexed: 06/11/2024]
Abstract
Human serum albumin (HSA) effectively binds to compounds having different molecular weight and thus facilitates their distribution in the living organisms. Thus, the binding interactions between a potential antibacterial drug (levofloxacin) and synthesized choline based levofloxacinate conjugates with HSA have been explored. The binding efficacy and mechanism were explored by utilizing different spectroscopic techniques; UV-Visible, steady state fluorescence, time resolved fluorescence and esterase-like activity. The interactions between the ligands and protein were electrostatic as well as hydrophobic in nature. The influence of different ligands having different alkyl chain shows quenching of the fluorescence emission of HSA. The spontaneous binding/quenching of HSA with ligands was static in nature, validated by steady state and time resolved fluorescence spectroscopy. Also, the impact of these ligands on the conformation of the native HSA structure was evaluated by using circular dichroism spectroscopy. In combination to the structural change study, the native protein functionality was observed (in terms of 'esterase-like activity') which has been found to be on lower side due to ligand binding. Further, we have performed the reverse study to check the impact of HSA on the fluorescent fluoroquinolone drug. The current study may prove helpful in elucidating the chemico-biological interactions which may prove useful in the pharmaceuticals, pharmacology, and different biochemistry fields.
Collapse
Affiliation(s)
- Ab Raouf Bhat
- Biophysical Chemistry Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India
| | - Rajan Patel
- Biophysical Chemistry Laboratory, Centre for Interdisciplinary Research in Basic Sciences, Jamia Millia Islamia, New Delhi, India.
| |
Collapse
|
3
|
Luo W, Chang G, Lin D, Xie H, Sun H, Li Z, Mo S, Wang R, Wang Y, Zheng Z. 3,3'-((3,4,5-trifluoropHenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) inhibit lung cancer cell proliferation and migration. PLoS One 2024; 19:e0303186. [PMID: 38776295 PMCID: PMC11111047 DOI: 10.1371/journal.pone.0303186] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [MESH Headings] [Grants] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 10/07/2023] [Accepted: 04/19/2024] [Indexed: 05/24/2024] Open
Abstract
Lung cancer is a major public health challenge and, despite therapeutic improvements, is the first leading cause of cancer worldwide. The current cure rate from advanced cancer treatment is excessively low. Therefore, it is of great importance to identify novel, potent and less toxic anticancer agents for the treatment of lung cancer. The aim of our research is to synthesize a new biscoumarin 3,3'-((3,4,5-trifluorop -phenyl)methylene)bis(4-hydroxy-2H-chromen-2-one) (C35) as an anticancer agent. C35 was simply prepared by 4-hydroxycoumarin and 3,4,5-trifluorobenzaldehyde under ethanol and its structure was analyzed by spectroscopic analyses. The anti-proliferation effect of C35 was detected using CCK-8 assay. Migration abilities were measured by Transwell assay. The expression of correlated proteins was determined by Western blot. The results showed that C35 displayed strong cytostatic effects on lung cancer cell proliferation. In addition, C35 possessed a significant inhibition of migration by reducing the expression of matrix metalloproteinases-2 (MMP-2) and MMP-9 in lung cancer cells. Furthermore, C35 treatment suppressed the phosphorylation of p38 in lung cancer cells. Moreover, in vivo experiments were carried out, in which we treated Lewis tumor-bearing C57 mice via intraperitoneal injection of C35. Results showed that C35 inhibited tumor growth in vivo. In conclusion, our study demonstrated the anticancer activity of C35 via suppression of lung cancer cell proliferation and migration, which is possibly involved with the inhibition of the p38 pathway.
Collapse
Affiliation(s)
- Wenhui Luo
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
- Guangdong Provincial Key Laboratory of Traditional Chinese Medicine Formula Granule, Guangdong Yifang Pharmaceutical Co., Ltd., Foshan, Guangdong Province, PR China
| | - Guoxin Chang
- College of Traditional Chinese Medicine, Guangdong Pharmacuetical University, Guangzhou, Guangdong Province, PR China
| | - Dingmei Lin
- College of Traditional Chinese Medicine, Guangdong Pharmacuetical University, Guangzhou, Guangdong Province, PR China
| | - Hongyi Xie
- College of Traditional Chinese Medicine, Guangdong Pharmacuetical University, Guangzhou, Guangdong Province, PR China
| | - Huilong Sun
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
| | - Zhibin Li
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
| | - Shirong Mo
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
| | - Ruixue Wang
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
| | - Yan Wang
- College of Traditional Chinese Medicine, Guangdong Pharmacuetical University, Guangzhou, Guangdong Province, PR China
| | - Zhaoguang Zheng
- School of Medicine, Foshan University, Foshan, Guangdong Province, PR China
| |
Collapse
|
4
|
Koley M, Han J, Soloshonok VA, Mojumder S, Javahershenas R, Makarem A. Latest developments in coumarin-based anticancer agents: mechanism of action and structure-activity relationship studies. RSC Med Chem 2024; 15:10-54. [PMID: 38283214 PMCID: PMC10809357 DOI: 10.1039/d3md00511a] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/19/2023] [Accepted: 10/20/2023] [Indexed: 01/30/2024] Open
Abstract
Many researchers around the world are working on the development of novel anticancer drugs with different mechanisms of action. In this case, coumarin is a highly promising pharmacophore for the development of novel anticancer drugs. Besides, the hybridization of this moiety with other anticancer pharmacophores has emerged as a potent breakthrough in the treatment of cancer to decrease its side effects and increase its efficiency. This review aims to provide a comprehensive overview of the recent development of coumarin derivatives and their application as novel anticancer drugs. Herein, we highlight and describe the largest number of research works reported in this field from 2015 to August 2023, along with their mechanisms of action and structure-activity relationship studies, making this review different from the other review articles published on this topic to date.
Collapse
Affiliation(s)
- Manankar Koley
- CSIR-Central Glass & Ceramic Research Institute Kolkata India
| | - Jianlin Han
- College of Chemical Engineering, Nanjing Forestry University Nanjing China
| | - Vadim A Soloshonok
- Department of Organic Chemistry I, University of the Basque Country San Sebastián Spain
- IKERBASQUE, Basque Foundation for Science Bilbao Spain
| | | | - Ramin Javahershenas
- Department of Organic Chemistry, Faculty of Chemistry, Urmia University Urmia Iran
| | - Ata Makarem
- Institute of Pharmacy, University of Hamburg Hamburg Germany
| |
Collapse
|
5
|
Toan DN, Thanh ND, Truong MX, Van DT, Thanh NN. Design, synthesis, molecular docking study and molecular dynamics simulation of new coumarin-pyrimidine hybrid compounds having anticancer and antidiabetic activity. Med Chem Res 2023; 32:1143-1162. [PMID: 37305206 PMCID: PMC10119543 DOI: 10.1007/s00044-023-03060-8] [Citation(s) in RCA: 2] [Impact Index Per Article: 2.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 01/24/2023] [Accepted: 04/06/2023] [Indexed: 06/13/2023]
Abstract
Coumarin-pyrimidine hybrid compounds were synthesized by condensation reaction of α,β-unsaturated ketones of 6-acetyl-5-hydroxy-4-methylcoumarin with guanidine. The reaction yields were of 42-62%. The antidiabetic and anticancer activities of these compounds were examined. These compounds displayed low toxicity to two cancer cell lines (including KB and HepG2 ones), but exhibited remarkably active against α-amylase with IC50 values of 102.32 ± 1.15 μM to 249.52 ± 1.14 μM and against α-glucosidase with IC50 values of 52.16 ± 1.12 μM to 184.52 ± 1.15 μM. Amongst these compounds, 6c was the best inhibitory activity against α-amylase, and 6f had the highest activity against α-glucosidase. The kinetics of inhibitor 6f was competitive α-glucosidase inhibitor property. ADMET predictions showed that almost all synthesized compounds exhibited drug-like activity. IFD and MD simulations were carried out on enzymes 4W93 and 5NN8 to elucidate inhibitory potential of 6c and 6f against tested enzymes. The binding free energy calculation by MM-GBSA approach showed that Coulomb, lipophilic and van der Waals energy terms are major contributors for the inhibitor binding. Molecular dynamics simulations in water solvent system were carried out for the 6f/5NN8 complex to elucidate the variability of active interactions between ligand 6f and active pockets of this enzyme. Graphical Abstract
Collapse
Affiliation(s)
- Duong Ngoc Toan
- Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen, Viet Nam
- Faculty of Chemistry, VNU University of Science, 19 Le Thanh Tong, Hoan Kiem, Ha Noi, Viet Nam
| | - Nguyen Dinh Thanh
- Faculty of Chemistry, VNU University of Science, 19 Le Thanh Tong, Hoan Kiem, Ha Noi, Viet Nam
| | - Mai Xuan Truong
- Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen, Viet Nam
| | - Dinh Thuy Van
- Faculty of Chemistry, Thai Nguyen University of Education, 20 Luong Ngoc Quyen, Thai Nguyen, Viet Nam
| | - Nguyen Ngoc Thanh
- Faculty of Chemical Technology, Ha Noi University of Industry, 298 Cau Dien Road, North Tu Liem, Ha Noi, Viet Nam
| |
Collapse
|
6
|
Reddy DS, Sinha A, Kurjogi MM, Shanavaz H, Kumar A. Design, synthesis, molecular docking, and biological evaluation of coumarin-thymidine analogs as potent anti-TB agents. Arch Pharm (Weinheim) 2023; 356:e2200633. [PMID: 36634969 DOI: 10.1002/ardp.202200633] [Citation(s) in RCA: 1] [Impact Index Per Article: 1.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 12/01/2022] [Revised: 12/21/2022] [Accepted: 12/23/2022] [Indexed: 01/14/2023]
Abstract
With the intent to discover new antituberculosis (TB) compounds, coumarin-thymidine analogs were synthesized using second-order nucleophilic substitution reactions of bromomethyl coumarin with thymidine. The newly synthesized coumarin-thymidine conjugates (1a-l) were characterized using IR, NMR, GC-MS, and CHN elemental analysis. The novel conjugates were found to exhibit potent anti-TB activity against the Mycobacterium tuberculosis H37 Rv strain, with minimum inhibitory concentrations (MIC) of the active compounds ranging between 0.012 and 0.482 µM. Compound 1k was established as the most active candidate with a MIC of 0.012 µM. The toxicity study on HEK cells confirmed the nontoxic nature of compounds 1e, 1h, 1i, 1j, and 1k. Also, the most active compounds (1k, 1j, and 1e) were stable in the pH range from 2.5 to 10, indicating compatibility with the biophysical environment. Based on the pKa studies, compounds 1k, 1j, and 1e are capable of crossing lipid-membrane barriers and acting on target cells. Molecular docking studies on the M. tuberculosis β-oxidation trifunctional enzyme (PDB ID: 7O4V) were conducted to investigate the mechanisms of anti-TB activity. All compounds showed excellent hydrogen binding interactions and exceptional docking scores against M. tuberculosis, which was in accordance with the results. Compounds 1a-l possessed excellent affinity to proteins, with binding energies ranging from -7.4 to -8.7 kcal/mol.
Collapse
Affiliation(s)
- Dinesh S Reddy
- Centre for Nano and Material Sciences, Jain (Deemed-to-be-University), Bangalore, Karnataka, India
| | - Anamika Sinha
- Centre for Nano and Material Sciences, Jain (Deemed-to-be-University), Bangalore, Karnataka, India
| | - Mahantesh M Kurjogi
- Multi-Disciplinary Research Unit, Karnataka Institute of Medical Sciences, Hubli, Karnataka, India
| | - H Shanavaz
- Department of Chemistry, Faculty of Engineering and Technology, Jain University, Bangalore, Karnataka, India
| | - Amit Kumar
- Centre for Nano and Material Sciences, Jain (Deemed-to-be-University), Bangalore, Karnataka, India
| |
Collapse
|
7
|
A Novel Ultrasound-Assisted Approach for the Synthesis of Biscoumarin and Bislawsone Derivatives Using rGO/TiO2 Nanocomposite as a Heterogeneous Catalyst. CHEMISTRY AFRICA 2023. [DOI: 10.1007/s42250-023-00587-6] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/12/2023]
|
8
|
Akki M, Reddy DS, Katagi KS, Kumar A, Devarajegowda HC, Kumari M S, Babagond V, Joshi SD. Coumarin Hydrazone Oxime Scaffolds as Potent Anti‐tubercular Agents: Synthesis, X‐ray crystal and Molecular Docking Studies. ChemistrySelect 2022. [DOI: 10.1002/slct.202203260] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/14/2022]
Affiliation(s)
- Mahesh Akki
- Research Centre Department of Chemistry Karnatak University's Karnatak Science College Dharwad 580001 Karnataka India
| | - Dinesh S. Reddy
- Centre for Nano and Material Sciences Jain University Jain Global Campus, Jakkasandra Post Bangalore 562112 Karnataka India
| | - Kariyappa S. Katagi
- Research Centre Department of Chemistry Karnatak University's Karnatak Science College Dharwad 580001 Karnataka India
| | - Amit Kumar
- Centre for Nano and Material Sciences Jain University Jain Global Campus, Jakkasandra Post Bangalore 562112 Karnataka India
| | | | - Sunitha Kumari M
- Department of Physics Yuvaraja's College University of Mysore Mysuru 570005 Karnataka India
| | - Vardhaman Babagond
- Research Centre Department of Chemistry Karnatak University's Karnatak Science College Dharwad 580001 Karnataka India
| | - Shrinivas D. Joshi
- Novel Drug Design and Discovery Laboratory Department of Pharmaceutical Chemistry S.E.T's College of Pharmacy Sangolli Rayanna Nagar Dharwad 580 002 Karnataka India
| |
Collapse
|
9
|
An insight on medicinal attributes of pyrimidine scaffold: An updated review. J Heterocycl Chem 2022. [DOI: 10.1002/jhet.4593] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/07/2022]
|
10
|
Akki M, Reddy DS, Katagi KS, Kumar A, Devarajegowda HC, M SK, Babagond V, Mane S, Joshi SD. Synthesis of coumarin-thioether conjugates as potential anti-tubercular agents: Their molecular docking and X-ray crystal studies. J Mol Struct 2022. [DOI: 10.1016/j.molstruc.2022.133452] [Citation(s) in RCA: 1] [Impact Index Per Article: 0.5] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 01/04/2023]
|
11
|
Sinha A, Chaudhary R, Reddy DS, Kongot M, Kurjogi MM, Kumar A. ON donor tethered copper (II) and vanadium (V) complexes as efficacious anti-TB and anti-fungal agents with spectroscopic approached HSA interactions. Heliyon 2022; 8:e10125. [PMID: 36033266 PMCID: PMC9403362 DOI: 10.1016/j.heliyon.2022.e10125] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Download PDF] [Figures] [Journal Information] [Subscribe] [Scholar Register] [Received: 06/01/2022] [Revised: 07/12/2022] [Accepted: 07/27/2022] [Indexed: 11/17/2022] Open
Abstract
Antimicrobial drug resistance poses a significant threat worldwide, hence triggering an urgent situation for developing feasible drugs. 3D-transition metal coordination complexes being multifaceted, offer tremendous potency as drug candidates. However, there are fewer reports on non-toxic and safe transition metal complexes; therefore, we hereby attempted to develop novel copper and vanadium-based therapeutic agents. We have synthesised six metal complexes viz., [VVO2(Quibal-INH)] (1), [CuII(Quibal-INH)2] (2), [VVO(Quibal-INH) (cat)] (3), [CuII(Quibal-INH) (cat)] (4), [VVO(Quibal-INH) (bha)] (5) and [CuII(Quibal-INH) (bha)] (6). Quibal-INH (L) is an ON bidentate donor ligand synthesized from Schiff base reaction between 4-(2-(7-chloroquinolin-3-yl)vinyl)benzaldehyde (Quibal) and Isoniazid (INH). The synthesized compounds were characterized using analytical techniques involving ATR-IR, UV-Vis, EPR, 1H NMR, 13C NMR, and 51V NMR. Ligand (L) and compound 3 exhibited moderate growth inhibitory activity towards Candida albicans and Cryptococcus neoformans fungal species. Compound 6 has been identified as active against the above fungal species with no toxicity and hemolysis activity on the healthy cells. Compound 5 exhibited significant activity against the Mycobacterium tuberculosis H 37 R v strain. Further, compounds 4, 5 and 6 exhibited excellent free radical scavenging activity. All the developed compounds were found to exhibit stability over a wide range of pH conditions. The complexes were additionally studied for their interaction with human serum albumin (HSA) with the UV-vis spectroscopic technique.
Collapse
Affiliation(s)
- Anamika Sinha
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, 562112, Karnataka, India
| | - Riya Chaudhary
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, 562112, Karnataka, India
| | - Dinesh S Reddy
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, 562112, Karnataka, India
| | - Manasa Kongot
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, 562112, Karnataka, India
| | - Mahantesh M Kurjogi
- Multi-Disciplinary Research Unit, Karnataka Institute of Medical Sciences, Hubli, India
| | - Amit Kumar
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Bengaluru, 562112, Karnataka, India
| |
Collapse
|
12
|
Sidat PS, Jaber TMK, Vekariya SR, Mogal AM, Patel AM, Noolvi M. Anticancer Biological Profile of Some Heterocylic Moieties-Thiadiazole, Benzimidazole, Quinazoline, and Pyrimidine. PHARMACOPHORE 2022. [DOI: 10.51847/rt6ve6gesu] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Subscribe] [Scholar Register] [Indexed: 01/07/2023]
|
13
|
Su Z, Zheng Z, Wang R, Xie H, Wang X, Liu Y. A synthetic biscoumarin suppresses lung cancer cell proliferation and induces cell apoptosis by increasing expression of RIP1. CHINESE J PHYSIOL 2022; 65:136-142. [DOI: 10.4103/cjp.cjp_107_21] [Citation(s) in RCA: 0] [Impact Index Per Article: 0] [Reference Citation Analysis] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 11/04/2022] Open
|
14
|
Reddy DS, Kongot M, Kumar A. Coumarin hybrid derivatives as promising leads to treat tuberculosis: Recent developments and critical aspects of structural design to exhibit anti-tubercular activity. Tuberculosis (Edinb) 2021; 127:102050. [PMID: 33540334 DOI: 10.1016/j.tube.2020.102050] [Citation(s) in RCA: 27] [Impact Index Per Article: 9.0] [Reference Citation Analysis] [Abstract] [Key Words] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Received: 09/01/2020] [Revised: 12/14/2020] [Accepted: 12/29/2020] [Indexed: 11/29/2022]
Abstract
Tuberculosis (TB) is a highly contagious airborne disease with nearly 25% of the world's population infected with it. Challenges such as multi drug resistant TB (MDR-TB), extensive drug resistant TB (XDR-TB) and in rare cases totally drug resistant TB (TDR-TB) emphasizes the critical and urgent need in developing novel TB drugs. Moreover, the prolonged and multi drug treatment regime suffers a major drawback due to high toxicity and vulnerability in TB patients. This calls for intensified research efforts in identifying novel molecular scaffolds which can combat these issues with minimal side effects. In this pursuit, researchers have screened many bio-active molecules among which coumarin have been identified as promising candidates for TB drug discovery and development. Coumarins are naturally occurring compounds known for their low toxicity and varied biological activity. The biological spectrum of coumarin has intrigued medicinal researchers to investigate coumarin scaffolds for their relevance as anti-TB drugs. In this review we focus on the recent developments of coumarin and its critical aspects of structural design required to exhibit anti-tubercular (anti-TB) activity. The information provided will help medicinal chemists to design and identify newer molecular analogs for TB treatment and also broadens the scope of exploring future generation potent yet safer coumarin based anti-TB agents.
Collapse
Affiliation(s)
- Dinesh S Reddy
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Jakkasandra Post, Bangalore, 562112, India
| | - Manasa Kongot
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Jakkasandra Post, Bangalore, 562112, India
| | - Amit Kumar
- Centre for Nano and Material Sciences, Jain University, Jain Global Campus, Jakkasandra Post, Bangalore, 562112, India.
| |
Collapse
|
15
|
Raza M, Jiang Y, Ahmad B, Rahman AU, Raza S, Khan A, Tahir K, Hassan S, Khan S, Yuan Q. Biophysical investigation of interactions between sorbic acid and human serum albumin through spectroscopic and computational approaches. NEW J CHEM 2021. [DOI: 10.1039/d0nj06276f] [Citation(s) in RCA: 4] [Impact Index Per Article: 1.3] [Reference Citation Analysis] [Abstract] [Track Full Text] [Journal Information] [Subscribe] [Scholar Register] [Indexed: 12/20/2022]
Abstract
This work provides an effective strategy to analyze the SA-induced microenvironmental changes in the HSA macromolecule, and also highlights the medicinal importance of SA.
Collapse
Affiliation(s)
- Muslim Raza
- Institute of Synthetic Biology
- Shenzhen Institutes of Advanced Technology
- Chinese Academy of Sciences
- Shenzhen
- China
| | - Yang Jiang
- State Key Laboratory of Chemical Resource Engineering
- College of Life Science and Technology
- Beijing University of Chemical Technology
- Beijing
- P. R. China
| | - Bashir Ahmad
- Centre of Biotechnology and Microbiology
- University of Peshawar
- Peshawar
- Pakistan
| | - Ata ur Rahman
- Institute of chemical sciences
- University of Peshawar
- Peshawar 25120
- Pakistan
| | - Saleem Raza
- College of Chemistry and Environmental Engineering
- Shenzhen University
- Shenzhen
- P. R. China
| | - Ajmal Khan
- Natural and Medical Sciences Research Centre
- University of Nizwa
- Nizwa 616
- Sultanate of Oman
| | - Kamran Tahir
- Institute of Chemical Sciences
- Gomal University
- D. I. Khan
- Pakistan
| | - Said Hassan
- Centre of Biotechnology and Microbiology
- University of Peshawar
- Peshawar
- Pakistan
| | - Saifullah Khan
- Centre of Biotechnology and Microbiology
- University of Peshawar
- Peshawar
- Pakistan
| | - Qipeng Yuan
- State Key Laboratory of Chemical Resource Engineering
- College of Life Science and Technology
- Beijing University of Chemical Technology
- Beijing
- P. R. China
| |
Collapse
|